Last year, the number of overdose deaths in the United States exceeded 100,000 for the first time ever. Equally alarming, the rate of drug-related overdose deaths among U.S. teenagers nearly doubled in 2020. Since that time, the data indicates that the mortality trend among adolescents is continuing, exacerbated by the nationwide mental health crisis, the COVID-19 pandemic, and ongoing barriers to evidence-based care for mental illness and substance use disorder (SUD) among teenagers.

In a new webinar, Manatt Health, the American Medical Association (AMA), and a panel of leading providers and SUD advocates with expertise in the youth and adolescent crisis will provide an overview of SUD among adolescents and discuss the challenges that states and communities face in addressing the substance abuse epidemic. We also will explore the consequences of failing to remove barriers to evidence-based care. Click here to register free. Key topics include:

• Trends in youth substance use, addiction and overdoses—and the related mental health crisis
• Major issues and barriers to address
• Federal and state policy options for responding
• The intersection of the substance abuse epidemic among youth and juvenile justice issues

Even if you can’t attend our live session on July 27, click here to register free now and receive a link to view the program on demand.

Speakers:

• Jocelyn Guyer, Managing Director, Manatt Health
• Daniel Blaney-Koen, Senior Legislative Attorney, AMA
• Sharon Levy, MD, MPH, Director of Adolescent Substance Use and Addiction Program, Boston Children’s Hospital and Associate Professor Pediatrics, Harvard Medical School
• Deepa R. Camenga, MD, MHS, FAAP, Associate Professor of Emergency Medicine, Pediatrics & Public Health; Associate Director for Pediatric Programs, Yale Program in Addiction Medicine; Yale Schools of Medicine & Public Health